Victory Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-102,188
| Closed | -$610K | – | 2512 |
|
2025
Q1 | $610K | Buy |
102,188
+429
| +0.4% | +$2.56K | ﹤0.01% | 1976 |
|
2024
Q4 | $782K | Buy |
101,759
+6,519
| +7% | +$50.1K | ﹤0.01% | 1906 |
|
2024
Q3 | $972K | Sell |
95,240
-15,149
| -14% | -$155K | ﹤0.01% | 1787 |
|
2024
Q2 | $1.64M | Buy |
110,389
+16,629
| +18% | +$247K | ﹤0.01% | 1499 |
|
2024
Q1 | $1.28M | Buy |
93,760
+13,967
| +18% | +$191K | ﹤0.01% | 1619 |
|
2023
Q4 | $874K | Sell |
79,793
-19,340
| -20% | -$212K | ﹤0.01% | 1781 |
|
2023
Q3 | $1.09M | Buy |
99,133
+351
| +0.4% | +$3.84K | ﹤0.01% | 1610 |
|
2023
Q2 | $1.31M | Buy |
98,782
+14,333
| +17% | +$190K | ﹤0.01% | 1543 |
|
2023
Q1 | $1.15M | Buy |
84,449
+20,857
| +33% | +$284K | ﹤0.01% | 1621 |
|
2022
Q4 | $1.24M | Buy |
63,592
+3,636
| +6% | +$71K | ﹤0.01% | 1618 |
|
2022
Q3 | $1.14M | Buy |
59,956
+4,845
| +9% | +$92.3K | ﹤0.01% | 1669 |
|
2022
Q2 | $1.14M | Buy |
55,111
+10,591
| +24% | +$218K | ﹤0.01% | 1683 |
|
2022
Q1 | $1.2M | Buy |
+44,520
| New | +$1.2M | ﹤0.01% | 1712 |
|